$HR
Healthcare Realty Trust Inc

2021 Q1 Form 10-Q Financial Statement

#000136060421000029 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $191.5M $185.8M
YoY Change 3.08% 9.95%
Cost Of Revenue $52.20M $49.60M
YoY Change 5.24% 16.16%
Gross Profit $78.10M $75.30M
YoY Change 3.72% 7.73%
Gross Profit Margin 40.78% 40.53%
Selling, General & Admin $8.500M $8.800M
YoY Change -3.41% 3.53%
% of Gross Profit 10.88% 11.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.10M $47.50M
YoY Change 5.47% 11.24%
% of Gross Profit 64.15% 63.08%
Operating Expenses $58.60M $56.20M
YoY Change 4.27% 9.77%
Operating Profit $19.50M $19.10M
YoY Change 2.09% 2.14%
Interest Expense $22.99M $23.87M
YoY Change -3.71% -0.41%
% of Operating Profit 117.88% 124.98%
Other Income/Expense, Net $3.000K $76.00K
YoY Change -96.05% -85.79%
Pretax Income $24.00M $4.300M
YoY Change 458.14% -12.24%
Income Tax
% Of Pretax Income
Net Earnings $22.03M $17.90M
YoY Change 23.07% 33.19%
Net Earnings / Revenue 11.5% 9.64%
Basic Earnings Per Share $0.10 $0.08
Diluted Earnings Per Share $0.10 $0.08
COMMON SHARES
Basic Shares Outstanding 218.8M shares 216.7M shares
Diluted Shares Outstanding 222.3M shares 220.6M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.10M $103.4M
YoY Change -88.3% 815.04%
Cash & Equivalents $29.99M $216.5M
Short-Term Investments
Other Short-Term Assets $47.00M $52.00M
YoY Change -9.62% 4.0%
Inventory
Prepaid Expenses
Receivables $12.00M $3.000M
Other Receivables $136.0M $135.0M
Total Short-Term Assets $12.10M $103.4M
YoY Change -88.3% 815.04%
LONG-TERM ASSETS
Property, Plant & Equipment $3.512B $3.455B
YoY Change 1.65% 9.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $64.00M $65.50M
YoY Change -2.29% -2.38%
Other Assets $64.60M $0.00
YoY Change -100.0%
Total Long-Term Assets $6.684B $6.721B
YoY Change -0.54% 7.86%
TOTAL ASSETS
Total Short-Term Assets $12.10M $103.4M
Total Long-Term Assets $6.684B $6.721B
Total Assets $6.697B $6.824B
YoY Change -1.87% 9.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.40M $64.60M
YoY Change 2.79% 5.04%
Accrued Expenses $91.90M $91.10M
YoY Change 0.88% 0.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.000M
YoY Change -100.0% -97.94%
Total Short-Term Liabilities $158.3M $155.7M
YoY Change 1.67% 2.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.628B $1.662B
YoY Change -2.07% 22.47%
Other Long-Term Liabilities $69.70M $70.10M
YoY Change -0.57% 49.79%
Total Long-Term Liabilities $1.698B $1.733B
YoY Change -2.01% 23.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $158.3M $155.7M
Total Long-Term Liabilities $1.698B $1.733B
Total Liabilities $3.508B $3.419B
YoY Change 2.58% 15.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $4.919B $4.912B
YoY Change 0.16% 8.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.998B $3.340B
YoY Change
Total Liabilities & Shareholders Equity $6.697B $6.824B
YoY Change -1.87% 9.32%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $22.03M $17.90M
YoY Change 23.07% 33.19%
Depreciation, Depletion And Amortization $50.10M $47.50M
YoY Change 5.47% 11.24%
Cash From Operating Activities $65.35M $75.42M
YoY Change -13.35% 55.33%
INVESTING ACTIVITIES
Capital Expenditures -$84.20M -$105.7M
YoY Change -20.34% 2.13%
Acquisitions
YoY Change
Other Investing Activities $14.40M -$2.500M
YoY Change -676.0% -56.14%
Cash From Investing Activities -$76.30M -$76.62M
YoY Change -0.42% 112.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.248M -$45.40M
YoY Change -107.15% -480.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$74.73M $185.1M
YoY Change -140.38% -338.59%
NET CHANGE
Cash From Operating Activities $65.35M $75.42M
Cash From Investing Activities -$76.30M -$76.62M
Cash From Financing Activities -$74.73M $185.1M
Net Change In Cash -$85.68M $183.9M
YoY Change -146.6% -382.62%
FREE CASH FLOW
Cash From Operating Activities $65.35M $75.42M
Capital Expenditures -$84.20M -$105.7M
Free Cash Flow $149.6M $181.1M
YoY Change -17.43% 19.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001360604
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-35568
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRUST OF AMERICA, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4738467
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
16435 N. Scottsdale Road, Suite 320,
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale,
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85254
CY2021Q1 dei City Area Code
CityAreaCode
(480)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
998-3478
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
HTA
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
400000 USD
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
218826453 shares
CY2021Q1 us-gaap Land
Land
596084000 USD
CY2020Q4 us-gaap Land
Land
596269000 USD
CY2021Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
6500503000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
6507816000 USD
CY2021Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
617774000 USD
CY2020Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
628621000 USD
CY2021Q1 us-gaap Development In Process
DevelopmentInProcess
95341000 USD
CY2020Q4 us-gaap Development In Process
DevelopmentInProcess
80178000 USD
CY2021Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
7809702000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
7812884000 USD
CY2021Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1738056000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1702719000 USD
CY2021Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6071646000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6110165000 USD
CY2021Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
36098000 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
63972000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
64360000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29990000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115407000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3096000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3358000 USD
CY2021Q1 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
251558000 USD
CY2020Q4 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
251728000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
230708000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
235223000 USD
CY2021Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
9523000 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
10451000 USD
CY2021Q1 us-gaap Assets
Assets
6696591000 USD
CY2020Q4 us-gaap Assets
Assets
6790692000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
3027732000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3026999000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
159226000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
200358000 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
3375000 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
12222000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
14957000 USD
CY2021Q1 hta Security Deposit Liability Advance Rentand Other Liabilities
SecurityDepositLiabilityAdvanceRentandOtherLiabilities
78433000 USD
CY2020Q4 hta Security Deposit Liability Advance Rentand Other Liabilities
SecurityDepositLiabilityAdvanceRentandOtherLiabilities
82553000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
195338000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
198367000 USD
CY2021Q1 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
31278000 USD
CY2020Q4 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
32539000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
3507604000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3555773000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
218823963 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218823963 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218578012 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
218578012 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2188000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2186000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4917126000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4916784000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14231000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16979000 USD
CY2021Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1775745000 USD
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1727752000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3129338000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3174239000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
59649000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
60680000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3188987000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3234919000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6696591000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6790692000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
191350000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
185531000 USD
CY2021Q1 us-gaap Interest Income Operating
InterestIncomeOperating
143000 USD
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
245000 USD
CY2021Q1 us-gaap Revenues
Revenues
191493000 USD
CY2020Q1 us-gaap Revenues
Revenues
185776000 USD
CY2021Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
59579000 USD
CY2020Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
56862000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10560000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11518000 USD
CY2021Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
96000 USD
CY2020Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
140000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76274000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
77665000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
22986000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
23872000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
169495000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
170057000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
1991000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
392000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
422000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
76000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
22393000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
18208000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
363000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
307000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
22030000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
17901000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218753000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216692000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222268000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220623000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
22393000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
18208000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2792000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-22498000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2792000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22498000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
25185000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4290000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
407000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-53000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24778000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4237000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3430644000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50020000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3203000 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4624000 USD
CY2020Q1 hta Noncontrolling Interestand Other Redeemed During Period Value
NoncontrollingInterestandOtherRedeemedDuringPeriodValue
0 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.315
CY2020Q1 us-gaap Dividends
Dividends
70001000 USD
CY2020Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
18208000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22498000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3404952000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3234919000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3337000 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3248000 USD
CY2021Q1 hta Noncontrolling Interestand Other Redeemed During Period Value
NoncontrollingInterestandOtherRedeemedDuringPeriodValue
0 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.320
CY2021Q1 us-gaap Dividends
Dividends
71206000 USD
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
22393000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2792000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3188987000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
22393000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
18208000 USD
CY2021Q1 hta Depreciation Amortizationand Other
DepreciationAmortizationandOther
71671000 USD
CY2020Q1 hta Depreciation Amortizationand Other
DepreciationAmortizationandOther
72949000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3337000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3203000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
392000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
422000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
785000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
885000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
1991000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-2275000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-1196000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-27613000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19662000 USD
CY2020Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2021Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
-7103000 USD
CY2020Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
1055000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65353000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75421000 USD
CY2021Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
30472000 USD
CY2020Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
41338000 USD
CY2021Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
17096000 USD
CY2020Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
12103000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
6420000 USD
CY2021Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
28931000 USD
CY2020Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
23793000 USD
CY2021Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
200000 USD
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
191000 USD
CY2021Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
CY2020Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
6000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76299000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76623000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
720000000 USD
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15000000 USD
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
415000000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
95602000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50020000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3248000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4624000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
70000000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
68227000 USD
CY2021Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1485000 USD
CY2020Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1509000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-74733000 USD
CY2021Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185058000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-85679000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
183856000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118765000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37616000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33086000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221472000 USD
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
Organization and Description of Business <div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership, in an umbrella partnership, or “UPREIT” structure. HTA has qualified and intends to continue to be taxed as a REIT for federal income tax purposes under the applicable sections of the Internal Revenue Code. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own real estate primarily consisting of medical office buildings (“MOBs”) located on or adjacent to hospital campuses or in off-campus, community core outpatient locations across 32 states within the United States, and we lease space to tenants primarily consisting of health systems, research and academic institutions, and various sized physician practices.  Through our full-service operating platform, we provide leasing, asset management, acquisitions, development and other related services for our properties. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary objective is to maximize stockholder value with growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing, building services and property management oversight; (ii) target accretive acquisitions and developments of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. Additionally, from time to time we consider, on an opportunistic basis, significant portfolio acquisitions that we believe fit our core business and we expect to enhance our existing portfolio. </span></div><div style="margin-top:3pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div>On March 11, 2020 the novel coronavirus disease (“COVID-19”) was declared a pandemic by the World Health Organization. As the virus continued to spread throughout the United States and other countries across the world, Federal, state and local governments took various actions including the issuance of “stay-at-home” orders, social distancing guidelines and ordering the temporary closure of non-essential businesses to limit the spread of COVID-19. While many businesses have reopened and vaccinations are becoming more widely available to the general population, the economic uncertainty created by the COVID-19 pandemic continue to present risks to the Company and the future results of our operations. Should current and planned measures, including further development and delivery of vaccines and other measures intended to reduce or eliminate the spread of COVID-19, past and/or proposed economic stimulus, and other laws, acts and orders proposed or enacted by these various governmental agencies ultimately not be successful or limited in their efficacy, our business and the broader real estate industry may experience significant adverse consequences. These consequences include loss of revenues, increased expenses, increased costs of materials, difficulty in maintaining an active workforce, and constraints on our ability to secure capital or financing, among other factors.
CY2021Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
32 state
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that effect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent asset and liabilities. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in adverse ways, and those estimates could be different under different assumptions or conditions.
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
64000000.0 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
64400000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29990000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
216515000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3096000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4957000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33086000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221472000 USD
CY2021Q1 hta Unusual Or Infrequent Item Or Both Deferred Rent Period
UnusualOrInfrequentItemOrBothDeferredRentPeriod
P3M
CY2020 hta Unusual Or Infrequent Item Or Both Rent Deferrals Granted In Period
UnusualOrInfrequentItemOrBothRentDeferralsGrantedInPeriod
11100000 USD
CY2021Q1 hta Unusual Or Infrequent Item Or Both Repayment Of Rent Deferrals
UnusualOrInfrequentItemOrBothRepaymentOfRentDeferrals
9200000 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
3375000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
400000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet
32900000 USD
CY2021Q1 hta Asset Acquisition Transaction Costs Capitalized
AssetAcquisitionTransactionCostsCapitalized
300000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand
1093000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand
2817000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements
26819000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements
35259000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases
3449000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases
3621000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases
79000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases
693000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases
66000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases
334000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests
876000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests
0 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet
30472000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet
41338000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet
2397000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet
334000 USD
CY2021Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet
32869000 USD
CY2020Q1 hta Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net
AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet
41672000 USD
CY2021Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P6Y4M24D
CY2020Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y4M24D
CY2021Q1 hta Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life
AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
P5Y8M12D
CY2020Q1 hta Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life
AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
P3Y9M18D
CY2021Q1 hta Aggregate Gross Sales Priceof Disposed Properties
AggregateGrossSalesPriceofDisposedProperties
0 USD
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
654866000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
666497000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
426223000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
427937000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
228643000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y7M6D
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
238560000 USD
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y7M6D
CY2021Q1 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
30673000 USD
CY2020Q4 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
29357000 USD
CY2021Q1 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
31278000 USD
CY2021Q1 hta Finite Lived Intangible Liabilities Weighted Average Remaining Life
FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife
P14Y8M12D
CY2020Q4 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
32539000 USD
CY2020 hta Finite Lived Intangible Liabilities Weighted Average Remaining Life
FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife
P14Y7M6D
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
12051000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
17717000 USD
CY2021Q1 us-gaap Other Receivables
OtherReceivables
5892000 USD
CY2020Q4 us-gaap Other Receivables
OtherReceivables
6243000 USD
CY2021Q1 hta Deferred Financing Costs Net
DeferredFinancingCostsNet
2155000 USD
CY2020Q4 hta Deferred Financing Costs Net
DeferredFinancingCostsNet
2586000 USD
CY2021Q1 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
42351000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
43234000 USD
CY2021Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
130221000 USD
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
128070000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
47172000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
46114000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11716000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7764000 USD
CY2021Q1 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
251558000 USD
CY2020Q4 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
251728000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2223000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1896000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
431000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
431000 USD
CY2020Q1 hta Number Of Ground Leases Commenced
NumberOfGroundLeasesCommenced
1 lease
CY2021Q1 hta Number Of Ground Leases Commenced
NumberOfGroundLeasesCommenced
1 lease
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7950000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
331000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10797000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
443000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10934000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
446000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10277000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
449000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9764000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
454000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9775000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
467000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
606571000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
26371000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
666068000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
28961000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
470730000 USD
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17189000 USD
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17189000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
195338000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
11772000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
11772000 USD
CY2021Q1 hta Operating Lease Lease Incomeand Other Lease Related Income
OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome
190400000 USD
CY2020Q1 hta Operating Lease Lease Incomeand Other Lease Related Income
OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome
184300000 USD
CY2021Q1 us-gaap Variable Lease Income
VariableLeaseIncome
45100000 USD
CY2020Q1 us-gaap Variable Lease Income
VariableLeaseIncome
42800000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
413951000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
519815000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
466157000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
411340000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
358711000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
314893000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
1167753000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3652620000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3050000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3050000000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
18409000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19157000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3859000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3844000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
3027732000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3026999000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
300000000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3050000000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200000000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q1 hta Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
2550000000 USD
CY2021Q1 hta Deferred Finance Costs Future Amortization Expense Remainder Of Fiscal Year
DeferredFinanceCostsFutureAmortizationExpenseRemainderOfFiscalYear
2244000 USD
CY2021Q1 hta Deferred Finance Costs Amortization Expense Year One
DeferredFinanceCostsAmortizationExpenseYearOne
2993000 USD
CY2021Q1 hta Deferred Finance Costs Amortization Expense Year Two
DeferredFinanceCostsAmortizationExpenseYearTwo
2497000 USD
CY2021Q1 hta Deferred Finance Costs Amortization Expense Year Three
DeferredFinanceCostsAmortizationExpenseYearThree
2104000 USD
CY2021Q1 hta Deferred Finance Costs Amortization Expense Year Four
DeferredFinanceCostsAmortizationExpenseYearFour
2092000 USD
CY2021Q1 hta Deferred Finance Costs Amortization Expense After Year Four
DeferredFinanceCostsAmortizationExpenseAfterYearFour
6479000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
18409000 USD
CY2021Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
6600000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
22393000 USD
CY2021Q1 hta Derivative Liability Including Interest Excluding Adjustment For Nonperformance Risk
DerivativeLiabilityIncludingInterestExcludingAdjustmentForNonperformanceRisk
12500000 USD
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000.0 USD
CY2021Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
300000000.0 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
71100000 USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
505000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
255000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
17901000 USD
CY2020Q1 hta Incremental Common Shares Attributable To Conversion Of Partnership Units
IncrementalCommonSharesAttributableToConversionOfPartnershipUnits
3676000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
0 shares
CY2020Q1 us-gaap Profit Loss
ProfitLoss
18208000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
363000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
307000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
22030000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218753000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216692000 shares
CY2021Q1 hta Incremental Common Shares Attributable To Conversion Of Partnership Units
IncrementalCommonSharesAttributableToConversionOfPartnershipUnits
3515000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
255000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222268000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220623000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
38605000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
34062000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4554000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3352000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19013000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8923000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
71146000 USD
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
69731000 USD
CY2021Q1 hta Noncash Redemption Of Noncontrolling Interests
NoncashRedemptionOfNoncontrollingInterests
255000 USD
CY2020Q1 hta Noncash Redemption Of Noncontrolling Interests
NoncashRedemptionOfNoncontrollingInterests
6776000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3995000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD

Files In Submission

Name View Source Status
0001360604-21-000029-index-headers.html Edgar Link pending
0001360604-21-000029-index.html Edgar Link pending
0001360604-21-000029.txt Edgar Link pending
0001360604-21-000029-xbrl.zip Edgar Link pending
a2021331ex311.htm Edgar Link pending
a2021331ex312.htm Edgar Link pending
a2021331ex313.htm Edgar Link pending
a2021331ex314.htm Edgar Link pending
a2021331ex321.htm Edgar Link pending
a2021331ex322.htm Edgar Link pending
a2021331ex323.htm Edgar Link pending
a2021331ex324.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hta-20210331.htm Edgar Link pending
hta-20210331.xsd Edgar Link pending
hta-20210331_cal.xml Edgar Link unprocessable
hta-20210331_def.xml Edgar Link unprocessable
hta-20210331_htm.xml Edgar Link completed
hta-20210331_lab.xml Edgar Link unprocessable
hta-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending